1. Home
  2. RDHL vs JNVR Comparison

RDHL vs JNVR Comparison

Compare RDHL & JNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • JNVR
  • Stock Information
  • Founded
  • RDHL 2009
  • JNVR 2018
  • Country
  • RDHL Israel
  • JNVR United States
  • Employees
  • RDHL N/A
  • JNVR N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • JNVR Finance: Consumer Services
  • Sector
  • RDHL Health Care
  • JNVR Finance
  • Exchange
  • RDHL Nasdaq
  • JNVR Nasdaq
  • Market Cap
  • RDHL 8.2M
  • JNVR 7.3M
  • IPO Year
  • RDHL N/A
  • JNVR 2023
  • Fundamental
  • Price
  • RDHL $5.85
  • JNVR $5.29
  • Analyst Decision
  • RDHL
  • JNVR
  • Analyst Count
  • RDHL 0
  • JNVR 0
  • Target Price
  • RDHL N/A
  • JNVR N/A
  • AVG Volume (30 Days)
  • RDHL 11.0K
  • JNVR 18.8K
  • Earning Date
  • RDHL 08-29-2024
  • JNVR 03-27-2025
  • Dividend Yield
  • RDHL N/A
  • JNVR N/A
  • EPS Growth
  • RDHL N/A
  • JNVR N/A
  • EPS
  • RDHL N/A
  • JNVR N/A
  • Revenue
  • RDHL $3,707,000.00
  • JNVR $1,820,969.00
  • Revenue This Year
  • RDHL $224.90
  • JNVR N/A
  • Revenue Next Year
  • RDHL $82.69
  • JNVR N/A
  • P/E Ratio
  • RDHL N/A
  • JNVR N/A
  • Revenue Growth
  • RDHL N/A
  • JNVR N/A
  • 52 Week Low
  • RDHL $5.41
  • JNVR $3.37
  • 52 Week High
  • RDHL $20.28
  • JNVR $11.84
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 40.41
  • JNVR 49.60
  • Support Level
  • RDHL $5.80
  • JNVR $4.88
  • Resistance Level
  • RDHL $6.26
  • JNVR $5.61
  • Average True Range (ATR)
  • RDHL 0.31
  • JNVR 0.63
  • MACD
  • RDHL 0.01
  • JNVR -0.03
  • Stochastic Oscillator
  • RDHL 19.33
  • JNVR 24.18

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About JNVR Janover Inc.

Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.

Share on Social Networks: